Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 9 February 2006. doi:10.1136/gut.2005.082107
Gut 2006;55:1114-1123
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2005.082107v1
55/8/1114    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, R K
Right arrow Articles by Satsangi, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, R K
Right arrow Articles by Satsangi, J

INFLAMMATORY BOWEL DISEASE

Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease

R K Russell1, H E Drummond1, E R Nimmo1, N H Anderson2, C L Noble1, D C Wilson3, P M Gillett4, P McGrogan5, K Hassan5, L T Weaver6, W M Bisset7, G Mahdi7, J Satsangi1

1 Gastrointestinal Unit, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK
2 Public Health Sciences, University of Edinburgh
3 Department of Child life and Health, University of Edinburgh and Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh
4 Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh
5 Department of Paediatric Gastroenterology, Yorkhill Hospital, Glasgow, UK
6 Department of Child Health, University of Glasgow
7 Department of Paediatric Gastroenterology, Royal Aberdeen Children’s Hospital, Aberdeen, UK

Correspondence to:
Correspondence to:
Dr R K Russell
Gastrointestinal Unit, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; richardkrussell71{at}hotmail.com

Background and aims: The OCTN1 (SLC22A4 1672C->T) and OCTN2 (SLC22A5 –207G->C) variants within the IBD5 locus have been associated with susceptibility to adult onset Crohn’s disease (CD), but their contribution in children has not been examined.

Methods: These OCTN1/2 variants and IBD5 marker single nucleotide polymorphisms (SNPs) (IGR2096a_1, IGR2198a_1, and IGR2230a_1) were examined in 299 Scottish children (200 with CD, 74 with ulcerative colitis (UC), and 25 with indeterminate colitis (IC)), together with 502 parents (for transmission disequilibrium testing) and 256 controls.

Results: All SNPs were in strong linkage disequilibrium (D' >0.94). TDT analysis showed association of the OCTN1 variant with inflammatory bowel disease (IBD) (p = 0.01) and CD (p = 0.04). Allele frequencies of the OCTN1/2 variants were significantly higher in IBD/CD cases (p<0.04). The homozygous mutant OCTN1/2 haplotype was increased in IBD (24.3% v 16.1%, p = 0.02) and UC (28.2% v 16.1%, p = 0.02) compared with controls. The OCTN1/2 variants were not independent of the background IBD5 risk haplotype in conferring disease susceptibility. Unifactorial analysis in CD patients showed that carriage of the TC haplotype was associated with lower weight, height, and BMI centile (<9th centile) at diagnosis (weight: 87.9% v 67.3% (p = 0.002), odds ratio (OR) = 3.52 (95% confidence interval, 1.51 to 8.22); height: 84.1% v 68.4% (p<0.05), OR = 2.44 (1.00 to 5.99); BMI: 79.6% v 61.1% (p = 0.02), OR = 2.49 (1.14 to 5.44)), and lower weight centile at follow up (87.5% v 64.6% (p = 0.03), OR = 3.83 (1.03 to 14.24)). Multifactorial binary logistic regression analysis confirmed association of the TC haplotype with lower weight centile at diagnosis (p = 0.02, OR = 3.41 (1.20 to 9.66)).

Conclusions: These data implicate variants within the IBD5 haplotype, as determinants of disease susceptibility and growth indices in early onset IBD. The OCTN1/2 variants remain potential positional candidate genes, but require further analysis.


Abbreviations: CD, Crohn’s disease; IBD, inflammatory bowel disease; IC, indeterminate colitis; SNP, single nucleotide polymorphism; UC, ulcerative colitis

Keywords: Crohn’s disease; ulcerative colitis; OCTN; IBD5; growth




This article has been cited by other articles:


Home page
GutHome page
C L Noble, A R Abbas, J Cornelius, C W Lees, G-T Ho, K Toy, Z Modrusan, N Pal, F Zhong, S Chalasani, et al.
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis
Gut, October 1, 2008; 57(10): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. R. Srinivas, P. D. Prasad, N. S. Umapathy, V. Ganapathy, and P. S. Shekhawat
Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1046 - G1053.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Van Limbergen, E. R. Nimmo, R. K. Russell, H. E. Drummond, L. Smith, N. H. Anderson, G. Davies, I. D. Arnott, D. C. Wilson, and J. Satsangi
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy
Hum. Mol. Genet., September 15, 2007; 16(18): 2175 - 2186.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Maeda, M. Hirayama, D. Kobayashi, K. Miyazawa, and I. Tamai
Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
Drug Metab. Dispos., March 1, 2007; 35(3): 394 - 401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology